Simplex Trading, LLC Dyne Therapeutics, Inc. Transaction History
Simplex Trading, LLC
- $195 Billion
- Q3 2025
A detailed history of Simplex Trading, LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 14,838 shares of DYN stock, worth $277,173. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,838
Previous 13,247
12.01%
Holding current value
$277,173
Previous $126,000
48.41%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding DYN
# of Institutions
220Shares Held
130MCall Options Held
36.5KPut Options Held
138K-
Vanguard Group Inc Valley Forge, PA9.76MShares$182 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$181 Million2.02% of portfolio
-
Janus Henderson Group PLC London, X09.44MShares$176 Million0.05% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$171 Million26.07% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$138 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $967M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...